Literature DB >> 8896500

Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

T van der Poll1, A Marchant, C V Keogh, M Goldman, S F Lowry.   

Abstract

The effects of recombinant interleukin (IL)-10 and the role of endogenous IL-10 were determined in C57B1/6 mice with pneumonia induced by intranasal inoculation with 10(6) cfu of Streptococcus pneumoniae. Pneumonia induced sustained expression of IL-10 mRNA and protein in lungs, but IL-10 remained undetectable in plasma. Intranasal inoculation of S. pneumoniae in combination with IL-10 (1500 U/mouse) resulted in decreased lung concentrations of tumor necrosis factor-alpha (TNF) and interferon (IFN)-gamma, increased bacterial counts in lungs and blood, and early lethality. Conversely, pretreatment (-2 h) of mice with an anti-IL-10 monoclonal antibody (2 mg/mouse) was associated with increased lung levels of TNF and IFN-gamma, reduced bacterial counts in lungs and plasma 40 h after the inoculation, and prolonged survival. These results indicate that during pneumococcal pneumonia, IL-10 attenuates the proinflammatory cytokine response within the lungs, hampers effective clearance of the infection, and shortens survival.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896500     DOI: 10.1093/infdis/174.5.994

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  76 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease.

Authors:  A R Kerr; P V Adrian; S Estevão; R de Groot; G Alloing; J-P Claverys; T J Mitchell; P W M Hermans
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 3.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

4.  Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Authors:  Spaska A Stanilova; Lyuba D Miteva; Zhivko T Karakolev; Chavdar S Stefanov
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

5.  CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection.

Authors:  Kaifeng Lisa Lin; Shari Sweeney; Brian Donghoon Kang; Elizabeth Ramsburg; Michael Dee Gunn
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 6.  Acute lower respiratory tract infection.

Authors:  Joseph P Mizgerd
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

7.  Lactobacillus curvatus WiKim38 isolated from kimchi induces IL-10 production in dendritic cells and alleviates DSS-induced colitis in mice.

Authors:  Sung-Gang Jo; Eui-Jeong Noh; Jun-Young Lee; Green Kim; Joo-Hee Choi; Mo-Eun Lee; Jung-Hee Song; Ji-Yoon Chang; Jong-Hwan Park
Journal:  J Microbiol       Date:  2016-06-28       Impact factor: 3.422

Review 8.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

9.  Intravenous Glutamine Administration Modulates TNF-α/IL-10 Ratio and Attenuates NFkB Phosphorylation in a Protein Malnutrition Model.

Authors:  Andressa Cristina Antunes Santos; Carolina Argondizo Correia; Dalila Cunha de Oliveira; Amanda Nogueira-Pedro; Primavera Borelli; Ricardo Ambrosio Fock
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

10.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.